• India
  • +91 98480 35983
  • India
  • USA
  • +1-408-508-5432
  • USA
  • Australia
  • +61-405-871-726
  • Australia
  • or
  • D-U-N-S : 854321383
  • LEI : 9845004484A1C4C82E71
  • MSME : UDYAM-TS-02-0059615

Portfolio of API's & Intermediates from Regulatory Qualified Co-Invested Manufacturers:

Sr No Product Regulated Status
USA EU
1OseltamivirDMF Filed
2VoriconazoleDMF FiledCEP
3RosuvastatinDMF FiledCEP
4RanolazineApproved
5RivaroxabanDMF FiledCEP
6CinacalcetDMF Filed
7FinofibrateDMF Filed
8FluconazoleDMF Filed
9TerbinafineDMF Filed
10LosartanDMF AvailableCEP
11MebeverineDMF Available
12IrbesartanDMF Available
Under Development Pipelines
Sr No Product Status
1Phenyltolaxymine CitrateUnder Development
2LubabegronUnder Development
3FelbinacValidation completed
4KetoprofenUnder Development
5Phenyltoloxamine citrateUnder Development
6ZeranolUnder Development
7Lubabegron FumerateUnder Development
8IsoxsuprineUnder Development
9MebendazolUnder Development
Intermediates with Validation Documentation
Sr No Product CAS Intermediate For API
1EATC: Ethyl-2-amino-1,3-thaizole-4 carboxylate5398-36-7Acotiamide
2TMBA: 2,4,5-trimethoxybenzoicacid490-64-2Acotiamide
3CBHP: 4-Chloro Benzhydryl Piperazine303-26-4Citerzine
4CODD - 8-Chloro-11-Oxo-10,11-dihydro-5H-debenzo-1,4 diazepine50892-62-1Closapine
55,6-Dimethoxy-2-(4-piperidinylmethyl)-1-indanone hydrochloride120013-39-0Donepezil
6MICA - 4-[5-[4-(Pentyloxy)phenyl]-3-isoxazolyl]benzoic acid179162-55-1Micafungin
72,3-dimethyl-2H-indazol-6-amine hydrochloride635702-60-2Pazopanib
82,3-Dimethyl-6-Nitro-2H-Indazole444731-73-1Pazopanib
92,4-Dichloropyrimidine3934-20-1Pazopanib
105-Amino-2-methylbenzenesulfonamide6973-09-7Pazopanib
11N-(2-chloropyrimidin4-yl)-2,3-dimethyl-2H-indazol6-amine444731-74-2Pazopanib
12Permethric acid chloride52314-67-7Permithrine
134-(4-(4-Aminophenyl)piperazine-1-yl)phenol74853-08-0Posaconazole
  • D-U-N-S: 854321383
  • LEI: 9845004484A1C4C82E71
  • MSME UDYAM-TS-02-0059615
Scroll To Top